Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia corporate presentation – June 2019 from adocia

Latest Press Releases

2019/09/09Number of shares and voting rights of ADOCIA as of August 31, 2019
2019/08/06Number of shares and voting rights of ADOCIA as of July 31st 2019

All Press releases

Next events

November 11-13, 2019 Bio-Europe Fall, Hamburg, Germany - Facilitating partnerships that drive life science dealmaking

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

September 25th, Adocia at the “Lyon Pole Bourse” Forum dedicated to investors

Adocia will be delivering an oral presentation at EASD next September 18th – Barcelona, Spain